Qiu Jiwan is the founder of Qyuns Therapeutics. Qyuns Therapeutics has raised $66M in total funding. Latest round: Series C. Based in Taizhou, China.
Qiu Jiwan serves as the Chairman of the Board and General Manager at Qyuns Therapeutics, a biotech firm specializing in the research and development of therapies for autoimmune and allergic illnesses. The company achieved a total revenue of RMB 807 million in 2025, marking a significant year-on-year increase.
Full founder directory · Investor directory · Company funding database · Fundraising library